Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Glutamine for Frequently Recurrent Herpes Labialis
NCT00913692Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2009
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of glutamine in herpes labialis, sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2009; status: terminated.
02
Drugs
glutamine
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT00913692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00913692.